RubrYc Therapeutics Spins Out Of HealthTell, Gets $10M
San Ramon-basd RubrYC Therapeutics, which says it is focused on using chemical libraries from HealthTell, Inc. to improve drug discovery throughput, has raised $10M in a Series A funding. The funding was led by Third Point Ventures, and also included Paladin Capital Group and Vital Venture Capital. RubrYc's CEO is Dr. Isaac Bright. The company said the funding completes its spin-off from HealthTell.
posted on Wednesday, April 11, 2018 (Link to more information)
Related companies:
RubrYc
Related stories:
> HealthTell Raises $26M For Healthcare Diagnostics
> Merck Buys Sirna Therapeutics
> Iconic Therapeutics Finds $20M
> PEAR Therapeutics Gets $50M For Treating Substance Abuse With Software
> Arete Therapeutics Raises $35M
silicontap.com Home